How US hemp ban could criminalize CBD products – and derail Medicare plan
Pilot program to reimburse patients for hemp-derived products could be undermined by ban passed by Congress
The Centers for Medicare and Medicaid Services recently started a new pilot to reimburse patients for hemp-derived products – like CBD – but a hemp ban that Congress passed in November could derail the program.
The new program will make certain Medicare and Medicaid recipients eligible for reimbursement for up to $500 worth of hemp products each year and is intended in part to evaluate whether these products could reduce their other health related costs. Continue reading...
What's Your Reaction?
like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0
